Cargando…
Effect of ancient Khorasan wheat on gut microbiota, inflammation, and short-chain fatty acid production in patients with fibromyalgia
BACKGROUND: Fibromyalgia (FM) syndrome is mainly characterized by widespread pain, sleeping disorders, fatigue, and cognitive dysfunction. In many cases, gastrointestinal distress is also reported, suggesting the potential pathogenic role of the gut microbiota (GM). The GM is deeply influenced by se...
Autores principales: | , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9150053/ https://www.ncbi.nlm.nih.gov/pubmed/35664958 http://dx.doi.org/10.3748/wjg.v28.i18.1965 |
_version_ | 1784717342188503040 |
---|---|
author | Baldi, Simone Pagliai, Giuditta Dinu, Monica Di Gloria, Leandro Nannini, Giulia Curini, Lavinia Pallecchi, Marco Russo, Edda Niccolai, Elena Danza, Giovanna Benedettelli, Stefano Ballerini, Giovanna Colombini, Barbara Bartolucci, Gianluca Ramazzotti, Matteo Sofi, Francesco Amedei, Amedeo |
author_facet | Baldi, Simone Pagliai, Giuditta Dinu, Monica Di Gloria, Leandro Nannini, Giulia Curini, Lavinia Pallecchi, Marco Russo, Edda Niccolai, Elena Danza, Giovanna Benedettelli, Stefano Ballerini, Giovanna Colombini, Barbara Bartolucci, Gianluca Ramazzotti, Matteo Sofi, Francesco Amedei, Amedeo |
author_sort | Baldi, Simone |
collection | PubMed |
description | BACKGROUND: Fibromyalgia (FM) syndrome is mainly characterized by widespread pain, sleeping disorders, fatigue, and cognitive dysfunction. In many cases, gastrointestinal distress is also reported, suggesting the potential pathogenic role of the gut microbiota (GM). The GM is deeply influenced by several environmental factors, especially the diet, and recent findings highlighted significant symptom improvement in FM patients following various nutritional interventions such as vegetarian diet, low-fermentable oligosaccharides, disaccharides, monosaccharides, and polyols based diets, gluten-free diet, and especially an ancient grain supplementation. In particular, a recent study reported that a replacement diet with ancient Khorasan wheat led to an overall improvement in symptom severity of FM patients. AIM: To examine the effects of ancient Khorasan wheat on the GM, inflammation, and short-chain fatty acid production in FM patients. METHODS: After a 2-wk run-in period, 20 FM patients were enrolled in this randomized, double-blind crossover trial. In detail, they were assigned to consume either Khorasan or control wheat products for 8 wk and then, following an 8-wk washout period, crossed. Before and after treatments, GM characterization was performed by 16S rRNA sequencing while the fecal molecular inflammatory response and the short-chain fatty acids (SCFAs) were respectively determined with the Luminex MAGPIX detection system and a mass chromatography-mass spectrometry method. RESULTS: The Khorasan wheat replacement diet, in comparison with the control wheat diet, had more positive effects on intestinal microbiota composition and on both the fecal immune and SCFAs profiles such as the significant increase of butyric acid levels (P = 0.054), candidatus Saccharibacteria (P = 9.95e-06) and Actinobacteria, and the reduction of Enterococcaceae (P = 4.97e-04). Moreover, the improvement of various FM symptoms along with the variation of some gut bacteria after the Khorasan wheat diet have been documented; in fact we reported positive correlations between Actinobacteria and both Tiredness Symptoms Scale (P < 0.001) and Functional Outcome of Sleep Questionnaire (P < 0.05) scores, between Verrucomicrobiae and both Widespread Pain Index (WPI) + Symptom Severity scale (SS) (P < 0.05) and WPI (P < 0.05) scores, between candidatus Saccharibacteria and SS score (P < 0.05), and between Bacteroidales and Sleep-Related and Safety Behaviour Questionnaire score (P < 0.05). CONCLUSION: The replacement diet based on ancient Khorasan wheat results in beneficial GM compositional and functional modifications that positively correlate with an improvement of FM symptomatology. |
format | Online Article Text |
id | pubmed-9150053 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Baishideng Publishing Group Inc |
record_format | MEDLINE/PubMed |
spelling | pubmed-91500532022-06-04 Effect of ancient Khorasan wheat on gut microbiota, inflammation, and short-chain fatty acid production in patients with fibromyalgia Baldi, Simone Pagliai, Giuditta Dinu, Monica Di Gloria, Leandro Nannini, Giulia Curini, Lavinia Pallecchi, Marco Russo, Edda Niccolai, Elena Danza, Giovanna Benedettelli, Stefano Ballerini, Giovanna Colombini, Barbara Bartolucci, Gianluca Ramazzotti, Matteo Sofi, Francesco Amedei, Amedeo World J Gastroenterol Basic Study BACKGROUND: Fibromyalgia (FM) syndrome is mainly characterized by widespread pain, sleeping disorders, fatigue, and cognitive dysfunction. In many cases, gastrointestinal distress is also reported, suggesting the potential pathogenic role of the gut microbiota (GM). The GM is deeply influenced by several environmental factors, especially the diet, and recent findings highlighted significant symptom improvement in FM patients following various nutritional interventions such as vegetarian diet, low-fermentable oligosaccharides, disaccharides, monosaccharides, and polyols based diets, gluten-free diet, and especially an ancient grain supplementation. In particular, a recent study reported that a replacement diet with ancient Khorasan wheat led to an overall improvement in symptom severity of FM patients. AIM: To examine the effects of ancient Khorasan wheat on the GM, inflammation, and short-chain fatty acid production in FM patients. METHODS: After a 2-wk run-in period, 20 FM patients were enrolled in this randomized, double-blind crossover trial. In detail, they were assigned to consume either Khorasan or control wheat products for 8 wk and then, following an 8-wk washout period, crossed. Before and after treatments, GM characterization was performed by 16S rRNA sequencing while the fecal molecular inflammatory response and the short-chain fatty acids (SCFAs) were respectively determined with the Luminex MAGPIX detection system and a mass chromatography-mass spectrometry method. RESULTS: The Khorasan wheat replacement diet, in comparison with the control wheat diet, had more positive effects on intestinal microbiota composition and on both the fecal immune and SCFAs profiles such as the significant increase of butyric acid levels (P = 0.054), candidatus Saccharibacteria (P = 9.95e-06) and Actinobacteria, and the reduction of Enterococcaceae (P = 4.97e-04). Moreover, the improvement of various FM symptoms along with the variation of some gut bacteria after the Khorasan wheat diet have been documented; in fact we reported positive correlations between Actinobacteria and both Tiredness Symptoms Scale (P < 0.001) and Functional Outcome of Sleep Questionnaire (P < 0.05) scores, between Verrucomicrobiae and both Widespread Pain Index (WPI) + Symptom Severity scale (SS) (P < 0.05) and WPI (P < 0.05) scores, between candidatus Saccharibacteria and SS score (P < 0.05), and between Bacteroidales and Sleep-Related and Safety Behaviour Questionnaire score (P < 0.05). CONCLUSION: The replacement diet based on ancient Khorasan wheat results in beneficial GM compositional and functional modifications that positively correlate with an improvement of FM symptomatology. Baishideng Publishing Group Inc 2022-05-14 2022-05-14 /pmc/articles/PMC9150053/ /pubmed/35664958 http://dx.doi.org/10.3748/wjg.v28.i18.1965 Text en ©The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved. https://creativecommons.org/licenses/by-nc/4.0/This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
spellingShingle | Basic Study Baldi, Simone Pagliai, Giuditta Dinu, Monica Di Gloria, Leandro Nannini, Giulia Curini, Lavinia Pallecchi, Marco Russo, Edda Niccolai, Elena Danza, Giovanna Benedettelli, Stefano Ballerini, Giovanna Colombini, Barbara Bartolucci, Gianluca Ramazzotti, Matteo Sofi, Francesco Amedei, Amedeo Effect of ancient Khorasan wheat on gut microbiota, inflammation, and short-chain fatty acid production in patients with fibromyalgia |
title | Effect of ancient Khorasan wheat on gut microbiota, inflammation, and short-chain fatty acid production in patients with fibromyalgia |
title_full | Effect of ancient Khorasan wheat on gut microbiota, inflammation, and short-chain fatty acid production in patients with fibromyalgia |
title_fullStr | Effect of ancient Khorasan wheat on gut microbiota, inflammation, and short-chain fatty acid production in patients with fibromyalgia |
title_full_unstemmed | Effect of ancient Khorasan wheat on gut microbiota, inflammation, and short-chain fatty acid production in patients with fibromyalgia |
title_short | Effect of ancient Khorasan wheat on gut microbiota, inflammation, and short-chain fatty acid production in patients with fibromyalgia |
title_sort | effect of ancient khorasan wheat on gut microbiota, inflammation, and short-chain fatty acid production in patients with fibromyalgia |
topic | Basic Study |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9150053/ https://www.ncbi.nlm.nih.gov/pubmed/35664958 http://dx.doi.org/10.3748/wjg.v28.i18.1965 |
work_keys_str_mv | AT baldisimone effectofancientkhorasanwheatongutmicrobiotainflammationandshortchainfattyacidproductioninpatientswithfibromyalgia AT pagliaigiuditta effectofancientkhorasanwheatongutmicrobiotainflammationandshortchainfattyacidproductioninpatientswithfibromyalgia AT dinumonica effectofancientkhorasanwheatongutmicrobiotainflammationandshortchainfattyacidproductioninpatientswithfibromyalgia AT diglorialeandro effectofancientkhorasanwheatongutmicrobiotainflammationandshortchainfattyacidproductioninpatientswithfibromyalgia AT nanninigiulia effectofancientkhorasanwheatongutmicrobiotainflammationandshortchainfattyacidproductioninpatientswithfibromyalgia AT curinilavinia effectofancientkhorasanwheatongutmicrobiotainflammationandshortchainfattyacidproductioninpatientswithfibromyalgia AT pallecchimarco effectofancientkhorasanwheatongutmicrobiotainflammationandshortchainfattyacidproductioninpatientswithfibromyalgia AT russoedda effectofancientkhorasanwheatongutmicrobiotainflammationandshortchainfattyacidproductioninpatientswithfibromyalgia AT niccolaielena effectofancientkhorasanwheatongutmicrobiotainflammationandshortchainfattyacidproductioninpatientswithfibromyalgia AT danzagiovanna effectofancientkhorasanwheatongutmicrobiotainflammationandshortchainfattyacidproductioninpatientswithfibromyalgia AT benedettellistefano effectofancientkhorasanwheatongutmicrobiotainflammationandshortchainfattyacidproductioninpatientswithfibromyalgia AT ballerinigiovanna effectofancientkhorasanwheatongutmicrobiotainflammationandshortchainfattyacidproductioninpatientswithfibromyalgia AT colombinibarbara effectofancientkhorasanwheatongutmicrobiotainflammationandshortchainfattyacidproductioninpatientswithfibromyalgia AT bartoluccigianluca effectofancientkhorasanwheatongutmicrobiotainflammationandshortchainfattyacidproductioninpatientswithfibromyalgia AT ramazzottimatteo effectofancientkhorasanwheatongutmicrobiotainflammationandshortchainfattyacidproductioninpatientswithfibromyalgia AT sofifrancesco effectofancientkhorasanwheatongutmicrobiotainflammationandshortchainfattyacidproductioninpatientswithfibromyalgia AT amedeiamedeo effectofancientkhorasanwheatongutmicrobiotainflammationandshortchainfattyacidproductioninpatientswithfibromyalgia |